According to @KobeissiLetter, President Trump said the 'Obamacare scam' led to massive increases in insurance company stock prices 'at the expense of the American people,' adding that insurers are 'making a killing' while coverage worsens. Source: @KobeissiLetter on X, Nov 9, 2025. The statement explicitly links the Affordable Care Act to health insurer share price appreciation, making U.S. health insurance and managed-care equities directly relevant for headline-driven trading attention. Source: @KobeissiLetter on X, Nov 9, 2025. The post does not mention cryptocurrencies or digital assets; no direct crypto market impact is stated. Source: @KobeissiLetter on X, Nov 9, 2025.

According to @ReutersBiz, President Donald Trump proposed redirecting federal funds from health insurance companies to individuals as a possible compromise to end the U.S. government shutdown while Congress remained deadlocked (source: Reuters Business). The reported shift targets federal disbursements tied to insurers, placing direct attention on insurer-related cash flows and policy risk for health insurance stocks, based on Reuters Business’ report (source: Reuters Business). For traders, the headline centers on shutdown resolution timing and the allocation of federal payments, which are core inputs for assessing managed-care revenue exposure, as reported by Reuters Business (source: Reuters Business).

According to Morgan Stanley and Goldman Sachs analyst reports, sell-side consensus expects Oscar Health ($OSCR) revenue growth to be negative in 2026 due to anticipated regulatory changes impacting Medicaid redeterminations and potential loss of key state contracts. Analysts also cite increased competitive pressures in the health insurance marketplace and slower member enrollment growth as contributing factors. These headwinds are expected to reduce premium revenues, directly affecting OSCR's top-line performance and potentially impacting related healthcare and digital health crypto tokens exposed to insurance sector trends (sources: Morgan Stanley Healthcare Quarterly, Goldman Sachs Oscar Health Equity Research, May 2024).